Overview Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea Status: Not yet recruiting Trial end date: 0000-00-00 Target enrollment: Participant gender: Summary The objective of this study is to monitor the usage of INLYTA® in real practice, including the adverse events associated with INLYTA®. Phase: N/A Details Lead Sponsor: PfizerTreatments: Axitinib